129 related articles for article (PubMed ID: 33956121)
1. Nitric oxide determines the development of actinomycetoma by Nocardia brasiliensis in eNOS knockout C57BL/6 mice.
Vazquez-Marmolejo AV; Lopez-Lopez N; Ascacio-Martinez JA; Valadez-Calderon JG; Espinoza-Martinez PE; Salinas-Carmona MC
FEMS Microbiol Lett; 2021 May; 368(8):. PubMed ID: 33956121
[TBL] [Abstract][Full Text] [Related]
2. Inducible nitric oxide synthase blockade with aminoguanidine, protects mice infected with Nocardia brasiliensis from actinomycetoma development.
Salinas-Carmona MC; Longoria-Lozano O; Garza-Esquivel HR; López-Ulloa J; Reyes-Carrillo J; Vázquez-Marmolejo AV
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008775. PubMed ID: 33091049
[TBL] [Abstract][Full Text] [Related]
3. Nocardia brasiliensis cell wall lipids modulate macrophage and dendritic responses that favor development of experimental actinomycetoma in BALB/c mice.
Trevino-Villarreal JH; Vera-Cabrera L; Valero-Guillén PL; Salinas-Carmona MC
Infect Immun; 2012 Oct; 80(10):3587-601. PubMed ID: 22851755
[TBL] [Abstract][Full Text] [Related]
4. Systemic increased immune response to Nocardia brasiliensis co-exists with local immunosuppressive microenvironment.
Salinas-Carmona MC; Rosas-Taraco AG; Welsh O
Antonie Van Leeuwenhoek; 2012 Oct; 102(3):473-80. PubMed ID: 22825801
[TBL] [Abstract][Full Text] [Related]
5. Immune response to Nocardia brasiliensis extracellular antigens in patients with mycetoma.
Castro-Matteotti B; Vera-Cabrera L; Ocampo-Candiani J; Rendón A; Salinas-Carmona MC; Welsh O
Mycopathologia; 2008 Mar; 165(3):127-34. PubMed ID: 18302006
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory effect of diethylcarbamazine in mice infected with Nocardia brasiliensis.
García-Hernández M; Castro-Corona MA; Segoviano-Ramírez JC; Brattig NW; Medina-De la Garza CE
Int Immunopharmacol; 2014 Nov; 23(1):113-20. PubMed ID: 25150175
[TBL] [Abstract][Full Text] [Related]
7. Immune response to Nocardia brasiliensis antigens in an experimental model of actinomycetoma in BALB/c mice.
Salinas-Carmona MC; Torres-Lopez E; Ramos AI; Licon-Trillo A; Gonzalez-Spencer D
Infect Immun; 1999 May; 67(5):2428-32. PubMed ID: 10225905
[TBL] [Abstract][Full Text] [Related]
8. IgM but not IgG monoclonal anti-Nocardia brasiliensis antibodies confer protection against experimental actinomycetoma in BALB/c mice.
Gonzalez-Suarez ML; Salinas-Carmona MC; Pérez-Rivera I
FEMS Immunol Med Microbiol; 2009 Oct; 57(1):17-24. PubMed ID: 19624737
[TBL] [Abstract][Full Text] [Related]
9. Review of 21 cases of mycetoma from 1991 to 2014 in Rio de Janeiro, Brazil.
Sampaio FM; Wanke B; Freitas DF; Coelho JM; Galhardo MC; Lyra MR; Lourenço MC; Paes RA; do Valle AC
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005301. PubMed ID: 28192433
[TBL] [Abstract][Full Text] [Related]
10. Construction of a Nocardia brasiliensis fluorescent plasmid to study Actinomycetoma pathogenicity.
Salinas-Carmona MC; Rocha-Pizaña MR
Plasmid; 2011 Jan; 65(1):25-31. PubMed ID: 20875450
[TBL] [Abstract][Full Text] [Related]
11. Nocardia brasiliensis induces formation of foamy macrophages and dendritic cells in vitro and in vivo.
Meester I; Rosas-Taraco AG; Salinas-Carmona MC
PLoS One; 2014; 9(6):e100064. PubMed ID: 24936860
[TBL] [Abstract][Full Text] [Related]
12. Nocardia brasiliensis: from microbe to human and experimental infections.
Salinas-Carmona MC
Microbes Infect; 2000 Sep; 2(11):1373-81. PubMed ID: 11018454
[TBL] [Abstract][Full Text] [Related]
13. Retnla down-regulation and IL-13-rich environment correlate with inflammation severity in experimental actinomycetoma by Nocardia brasiliensis.
Meester I; Rosas-Taraco AG; Salinas-Carmona MC
Pathog Dis; 2013 Apr; 67(3):214-20. PubMed ID: 23620185
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and treatment of actinomycetoma in northeast Mexico: A case series.
Cárdenas-de la Garza JA; Welsh O; Cuéllar-Barboza A; Suarez-Sánchez KP; De la Cruz-Valadez E; Cruz-Gómez LG; Gallardo-Rocha A; Ocampo-Candiani J; Vera-Cabrera L
PLoS Negl Trop Dis; 2020 Feb; 14(2):e0008123. PubMed ID: 32097417
[TBL] [Abstract][Full Text] [Related]
15. Case report: Actinomycetoma caused by Nocardia aobensis from Lao PDR with favourable outcome after short-term antibiotic treatment.
Vongphoumy I; Dance DA; Dittrich S; Logan J; Davong V; Rattanavong S; Blessmann J
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003729. PubMed ID: 25879445
[TBL] [Abstract][Full Text] [Related]
16. [Immunoglobulins in patients with Nocardia brasiliensis actinomycetoma].
Méndez-Tovar LJ; Mondragón-González R; Manzano-Gayosso P; López-Martínez R; Hernández-Hernández F; Bonifaz A; Anides Fonseca A; Araiza J; Vega-López F
Rev Argent Microbiol; 2004; 36(4):174-8. PubMed ID: 15786870
[TBL] [Abstract][Full Text] [Related]
17. Genetic variability of the 16S rRNA gene of Nocardia brasiliensis, the most common causative agent of actinomycetoma in Latin America and the Caribbean.
Cruz-Medrano MG; Manzanares-Leal GL; González-Nava J; Moreno-Pérez PA; Sandoval-Trujillo H; Ramírez-Durán N
Rev Inst Med Trop Sao Paulo; 2023; 65():e31. PubMed ID: 37075338
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of DA-7218, a new oxazolidinone prodrug, in the treatment of experimental actinomycetoma produced by Nocardia brasiliensis.
Espinoza-González NA; Welsh O; de Torres NW; Cavazos-Rocha N; Ocampo-Candiani J; Said-Fernandez S; Lozano-Garza G; Choi SH; Vera-Cabrera L
Molecules; 2008 Jan; 13(1):31-40. PubMed ID: 18259127
[TBL] [Abstract][Full Text] [Related]
19. Mycetoma in China: A Case Report and Review of the Literature.
Wang R; Yao X; Li R
Mycopathologia; 2019 Apr; 184(2):327-334. PubMed ID: 30887177
[TBL] [Abstract][Full Text] [Related]
20. Actinomycetoma in arm disseminated to lung with grains of Nocardia brasiliensis with peripheral filaments.
Muñoz-Hernández B; Noyola MC; Palma-Cortés G; Rosete DP; Galván MA; Manjarrez ME
Mycopathologia; 2009 Jul; 168(1):37-40. PubMed ID: 19238584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
